{
  "ticker": "LLY",
  "target_date": "2025-06-19",
  "actual_date": "2025-06-18",
  "collected_at": "2025-12-08T11:54:52.385705",
  "price": {
    "open": 787.06,
    "high": 787.74,
    "low": 776.59,
    "close": 782.160888671875,
    "volume": 2442900,
    "change_1d_pct": -0.78,
    "change_7d_pct": 1.46,
    "change_30d_pct": 1.49
  },
  "technicals": {
    "rsi_14": 73.76,
    "sma_20": 760.35,
    "sma_50": 773.29,
    "macd": 9.71,
    "macd_signal": 4.368,
    "macd_histogram": 5.342,
    "bb_upper": 832.96,
    "bb_lower": 687.74,
    "price_vs_sma20_pct": 2.87,
    "price_vs_sma50_pct": 1.15,
    "volume_ratio": 0.75
  },
  "fundamentals": {
    "market_cap": 892270346240,
    "pe_ratio": 48.76678,
    "forward_pe": 43.924538,
    "price_to_book": 37.474777,
    "price_to_sales": 15.016381,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.49,
    "pct_from_52w_low": 59.56
  },
  "macro": {
    "spy": {
      "price": 594.03,
      "change_1d_pct": -0.02,
      "change_7d_pct": -0.94
    },
    "vix": {
      "level": 20.14,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.4
    },
    "dollar_index": {
      "level": 98.91
    },
    "gold": {
      "price": 3389.8
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly (NYSE:LLY) Faces $7 Billion Lawsuit While Partnering With Innovative Biotech",
      "source": "Yahoo",
      "datetime": 1750354400,
      "summary": "Eli Lilly (NYSE:LLY) has been in the spotlight recently with a 3.96% share price increase over the past month. The selection of RyboDyn Inc. to join Lilly Gateway Labs stands out among recent developments, signaling strengthened research capabilities in precision immunotherapies and potentially bols",
      "url": "https://finnhub.io/api/news?id=a402e4c9f5e745d2ce8682066332eeec2aa700fbc8482fe307419d2345d4ea62"
    },
    {
      "headline": "What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?",
      "source": "Yahoo",
      "datetime": 1750342980,
      "summary": "LLY's $1.3 billion Verve deal marks its third M&A in 2025 as it pushes to diversify across cardiovascular, neuro and cancer therapies.",
      "url": "https://finnhub.io/api/news?id=671bceb1503c75560f2191e89a2d40373d0d521150c0da86026f66bb88304848"
    },
    {
      "headline": "SanDisk initiated, Analog Devices upgraded: Wall Street\u2019s top analyst calls",
      "source": "Yahoo",
      "datetime": 1750340738,
      "summary": "The most talked about and market moving research calls around Wall Street are now in one place. Here are today\u2019s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Cantor Fitzgerald upgraded Analog Devices (ADI) to Overweight from Neutral with a price target of $270,",
      "url": "https://finnhub.io/api/news?id=1492fe234c164999b387864c252e89730a3be937ed33f5f3b8f1b9ab22a41a81"
    },
    {
      "headline": "RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome",
      "source": "Yahoo",
      "datetime": 1750334580,
      "summary": "RyboDyn, Inc., a biotechnology company pioneering first-in-class immunotherapies targeting the dark proteome, today announced its selection to join Lilly Gateway Labs (LGL) in San Diego, an innovation hub operated with Alexandria Real Estate Equities, Inc. This selection provides RyboDyn with direct",
      "url": "https://finnhub.io/api/news?id=24be2c8a3f81f5104d32bf705c0306d1f48fd0d5f71b64340e45e180d419d23b"
    },
    {
      "headline": "How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl",
      "source": "Yahoo",
      "datetime": 1750334437,
      "summary": "In the battle for weight-loss supremacy, Hims & Hers Health has emerged as a dark horse candidate shaking up the market.",
      "url": "https://finnhub.io/api/news?id=fb958c96dcdd5260d172c1218f5b1f54bc21509a9afc5db51e57c77fd2ef6641"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199300.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000176/xslF345X05/wk-form4_1750199300.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199159.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000174/xslF345X05/wk-form4_1750199159.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198988.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000172/xslF345X05/wk-form4_1750198988.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198711.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000170/xslF345X05/wk-form4_1750198711.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198504.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000168/xslF345X05/wk-form4_1750198504.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}